Technical Analysis for BIOA - BioAge Labs, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 18.50 | 0.54% | 0.10 |
BIOA closed down 4.02 percent on Wednesday, November 20, 2024, on 67 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | N/A | N/A | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| NR7 | Range Contraction | 0.54% | |
| NR7-2 | Range Contraction | 0.54% | |
| Wide Bands | Range Expansion | 0.54% | |
| Oversold Stochastic | Weakness | 0.54% | |
| Stochastic Buy Signal | Bullish | -3.50% | |
| NR7 | Range Contraction | -3.50% | |
| Lower Bollinger Band Walk | Weakness | -3.50% | |
| Inside Day | Range Contraction | -3.50% | |
| Wide Bands | Range Expansion | -3.50% | |
| Oversold Stochastic | Weakness | -3.50% |
| Alert | Time |
|---|---|
| Down 1% | 6 minutes ago |
| Rose Above Previous Day's High | 24 minutes ago |
| Up 5% | 24 minutes ago |
| Up 3% | 24 minutes ago |
| Up 2% | 31 minutes ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: Unknown
BioAge Labs, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapeutic products for metabolic diseases, such as obesity, by targeting the biology of human beings. It offers Azelaprag, a potential oral therapeutic for obesity, followed by several earlier-stage metabolic programs. The company was founded by Kristen Fortney and Eric Morgen on April 1, 2015 and is headquartered in Richmond, CA.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Biopharmaceutical Medication Obesity Therapeutic Products Metabolic Disease Nutrition Bariatrics
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Biopharmaceutical Medication Obesity Therapeutic Products Metabolic Disease Nutrition Bariatrics
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 26.62 |
| 52 Week Low | 18.0 |
| Average Volume | 337,903 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 0.00 |
| 20-Day Moving Average | 21.69 |
| 10-Day Moving Average | 19.91 |
| Average True Range | 1.78 |
| RSI (14) | 39.02 |
| ADX | 22.78 |
| +DI | 9.87 |
| -DI | 21.54 |
| Chandelier Exit (Long, 3 ATRs) | 21.29 |
| Chandelier Exit (Short, 3 ATRs) | 23.33 |
| Upper Bollinger Bands | 26.09 |
| Lower Bollinger Band | 17.30 |
| Percent B (%b) | 0.13 |
| BandWidth | 40.53 |
| MACD Line | -0.92 |
| MACD Signal Line | -0.39 |
| MACD Histogram | -0.5353 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 20.01 | ||||
| Resistance 3 (R3) | 20.09 | 19.63 | 19.74 | ||
| Resistance 2 (R2) | 19.63 | 19.22 | 19.59 | 19.65 | |
| Resistance 1 (R1) | 19.02 | 18.97 | 18.79 | 18.94 | 19.56 |
| Pivot Point | 18.56 | 18.56 | 18.45 | 18.52 | 18.56 |
| Support 1 (S1) | 17.95 | 18.15 | 17.72 | 17.87 | 17.24 |
| Support 2 (S2) | 17.49 | 17.90 | 17.45 | 17.15 | |
| Support 3 (S3) | 16.88 | 17.49 | 17.06 | ||
| Support 4 (S4) | 16.80 |
